WallStSmart

Red Violet Inc (RDVT)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 187% more annual revenue ($258.90M vs $90.25M). RDVT leads profitability with a 14.6% profit margin vs -15.5%. RDVT earns a higher WallStSmart Score of 46/100 (D+).

RDVT

Hold

46

out of 100

Grade: D+

Growth: 8.7Profit: 6.5Value: 5.0Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

RDVTUndervalued (+7.6%)

Margin of Safety

+7.6%

Fair Value

$44.52

Current Price

$37.43

$7.09 discount

UndervaluedFair: $44.52Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

RDVT2 strengths · Avg: 9.0/10
EPS GrowthGrowth
215.2%10/10

Earnings expanding 215.2% YoY

Revenue GrowthGrowth
19.6%8/10

19.6% revenue growth

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

RDVT2 concerns · Avg: 2.5/10
Market CapQuality
$528.37M3/10

Smaller company, higher risk/reward

P/E RatioValuation
41.1x2/10

Premium valuation, high expectations priced in

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : RDVT

The strongest argument for RDVT centers on EPS Growth, Revenue Growth. Revenue growth of 19.6% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : RDVT

The primary concerns for RDVT are Market Cap, P/E Ratio. A P/E of 41.1x leaves little room for execution misses.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

RDVT profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.

RDVT carries more volatility with a beta of 1.81 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

RDVT scores higher overall (46/100 vs 41/100) and 19.6% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Red Violet Inc

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Red Violet, Inc., a software and services company, specializes in proprietary technologies and applies analytical capabilities to deliver identity intelligence in the United States. The company is headquartered in Boca Raton, Florida.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?